Literature DB >> 25037112

Impact of thin-cap fibroatheroma on predicting deteriorated coronary flow during interventional procedures in acute as well as stable coronary syndromes: insights from optical coherence tomography analysis.

Tadatsugu Gamou1, Kenji Sakata1, Takao Matsubara2, Toshihiko Yasuda2, Kenji Miwa2, Masaru Inoue2, Honin Kanaya2, Tetsuo Konno1, Kenshi Hayashi1, Masaaki Kawashiri1, Masakazu Yamagishi3.   

Abstract

The occurrence of deteriorated coronary flow associated with distal embolization during percutaneous coronary intervention results in impaired myocardial perfusion and worsens the clinical prognosis. This study aimed to examine the impact of optical coherence tomography (OCT)-determined coronary plaque morphology on the prediction of deteriorated coronary flow after stent implantation in acute as well as stable coronary syndromes (ACS and SAP, respectively). We studied 126 patients who underwent OCT during stenting for ACS (n = 44) and SAP (n = 82) with a de novo lesion. Angiographic deteriorated coronary flow was defined as the deterioration of TIMI flow grade after mechanical dilatation in the absence of a mechanical obstruction on angiograms. Patients could be divided into the deteriorated flow group (n = 21) and the reflow group (n = 105). Under these conditions, the presence of thin-cap fibroatheroma (TCFA) was more frequently observed in the deteriorated flow group than in the reflow group in both ACS and SAP. A multivariable logistic regression model revealed that TCFA was an independent predictor of deteriorated coronary flow (hazard ratio: 12.32; 95 % confidence interval: 3.02-50.31; p = 0.0005). These results demonstrate that TCFA detected by OCT could be a strong predictor of the occurrence of deteriorated coronary flow during stent implantation in ACS as well as SAP.

Entities:  

Keywords:  Acute coronary syndrome; No-reflow phenomenon; Optical coherence tomography; Percutaneous coronary intervention; Stable angina

Mesh:

Year:  2014        PMID: 25037112     DOI: 10.1007/s00380-014-0542-3

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  30 in total

1.  Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention.

Authors:  Ronen Jaffe; Thierry Charron; Geoffrey Puley; Alexander Dick; Bradley H Strauss
Journal:  Circulation       Date:  2008-06-17       Impact factor: 29.690

2.  Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation.

Authors:  Tetsumin Lee; Taishi Yonetsu; Kenji Koura; Keiichi Hishikari; Tadashi Murai; Toshiyuki Iwai; Takamitsu Takagi; Yoshito Iesaka; Hideomi Fujiwara; Mitsuaki Isobe; Tsunekazu Kakuta
Journal:  Circ Cardiovasc Interv       Date:  2011-07-26       Impact factor: 6.546

3.  Filter no reflow during percutaneous coronary interventions using the Filterwire distal protection device.

Authors:  I Porto; R P Choudhury; P Pillay; F Burzotta; C Trani; G Niccoli; D J Blackman; K M Channon; A P Banning
Journal:  Int J Cardiol       Date:  2005-08-09       Impact factor: 4.164

4.  The distal protection during primary percutaneous coronary intervention alleviates the adverse effects of large thrombus burden on myocardial reperfusion.

Authors:  Hisashi Umeda; Toshiaki Katoh; Mitsunori Iwase; Hideo Izawa; Kohzo Nagata; Kosuke Watanabe; Taro Okada; Takumi Yamada; Tomomitsu Tani; Toyoaki Matsushita; Yoshimasa Murakami; Mitsuhiro Okamoto; Takeshi Shimizu; Toyoaki Murohara; Mitsuhiro Yokota
Journal:  Circ J       Date:  2006-03       Impact factor: 2.993

5.  Predicting angiographic distal embolization following percutaneous coronary intervention in patients with acute myocardial infarction.

Authors:  Daiju Fukuda; Atsushi Tanaka; Kenei Shimada; Yukio Nishida; Takahiko Kawarabayashi; Junichi Yoshikawa
Journal:  Am J Cardiol       Date:  2003-02-15       Impact factor: 2.778

6.  Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy.

Authors:  Takashi Kubo; Toshio Imanishi; Shigeho Takarada; Akio Kuroi; Satoshi Ueno; Takashi Yamano; Takashi Tanimoto; Yoshiki Matsuo; Takashi Masho; Hironori Kitabata; Kazushi Tsuda; Yoshiaki Tomobuchi; Takashi Akasaka
Journal:  J Am Coll Cardiol       Date:  2007-08-20       Impact factor: 24.094

7.  Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardial infarction who had angioscopically defined ruptured plaque.

Authors:  Isamu Mizote; Yasunori Ueda; Tomohito Ohtani; Masahiko Shimizu; Yasuharu Takeda; Takafumi Oka; Masahiko Tsujimoto; Atsushi Hirayama; Masatsugu Hori; Kazuhisa Kodama
Journal:  Circulation       Date:  2005-08-16       Impact factor: 29.690

8.  Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study.

Authors:  J H Bae; T-G Kwon; D-W Hyun; C S Rihal; A Lerman
Journal:  Heart       Date:  2008-04-01       Impact factor: 5.994

9.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.

Authors: 
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

10.  Repeated occurrence of slow flow phenomenon during and late after sirolimus-eluting stent implantation.

Authors:  Kenji Sakata; Masanobu Namura; Toshimitsu Takagi; Naoto Tama; Isao Inoki; Hidenobu Terai; Yuki Horita; Masatoshi Ikeda; Masakazu Yamagishi
Journal:  Heart Vessels       Date:  2014-01-30       Impact factor: 2.037

View more
  5 in total

1.  Assessment of vascular response after drug-eluting stents implantation in patients with diabetes mellitus: an optical coherence tomography sub-study of the J-DESsERT.

Authors:  Takashi Kubo; Takashi Akasaka; Takashi Tanimoto; Masamichi Takano; Yoshitane Seino; Kenya Nasu; Tomonori Itoh; Kyoichi Mizuno; Hiroyuki Okura; Toshiro Shinke; Jun-Ichi Kotani; Shigenori Ito; Hiroyoshi Yokoi; Toshiya Muramatsu; Masato Nakamura; Shinsuke Nanto
Journal:  Heart Vessels       Date:  2015-01-29       Impact factor: 2.037

2.  Coronary plaque rupture with subsequent thrombosis typifies the culprit lesion of non-ST-segment-elevation myocardial infarction, not unstable angina: non-ST-segment-elevation acute coronary syndrome study.

Authors:  Mikumo Sakaguchi; Shoichi Ehara; Takao Hasegawa; Kenji Matsumoto; Satoshi Nishimura; Junichi Yoshikawa; Kenei Shimada
Journal:  Heart Vessels       Date:  2016-06-21       Impact factor: 2.037

3.  The utility of total lipid core burden index/maximal lipid core burden index ratio within the culprit plaque to predict filter-no reflow: insight from near-infrared spectroscopy with intravascular ultrasound.

Authors:  Takao Sato; Yoshifusa Aizawa; Naomasa Suzuki; Yuji Taya; Sho Yuasa; Shohei Kishi; Tomoyasu Koshikawa; Koichi Fuse; Satoshi Fujita; Yoshio Ikeda; Hitoshi Kitazawa; Minoru Takahashi; Masaaki Okabe
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

4.  Impact of Distal Protection with Filter-Type Device on Long-term Outcome after Percutaneous Coronary Intervention for Acute Myocardial Infarction: Clinical Results with Filtrap®.

Authors:  Ryota Teramoto; Kenji Sakata; Kenji Miwa; Takao Matsubara; Toshihiko Yasuda; Masaru Inoue; Hirofumi Okada; Honin Kanaya; Masa-Aki Kawashiri; Masakazu Yamagishi; Kenshi Hayashi
Journal:  J Atheroscler Thromb       Date:  2016-06-02       Impact factor: 4.928

5.  The combination assessment of lipid pool and thrombus by optical coherence tomography can predict the filter no-reflow in primary PCI for ST elevated myocardial infarction.

Authors:  Yosuke Negishi; Hideki Ishii; Susumu Suzuki; Toshijiro Aoki; Naoki Iwakawa; Hiroki Kojima; Kazuhiro Harada; Kenshi Hirayama; Takayuki Mitsuda; Takuya Sumi; Akihito Tanaka; Yasuhiro Ogawa; Katsuhiro Kawaguchi; Toyoaki Murohara
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.